investorscraft@gmail.com

Intrinsic Value of Stepan Company (SCL)

Previous Close$59.02
Intrinsic Value
Upside potential
Previous Close
$59.02

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Stepan Company operates as a global producer of specialty and intermediate chemicals, serving diverse industries such as surfactants, polymers, and agricultural products. The company generates revenue through the manufacture and sale of chemical solutions tailored for household, industrial, and institutional applications, including detergents, lubricants, and coatings. Its surfactants segment, a key revenue driver, caters to consumer and industrial cleaning markets, while its polymer segment supplies rigid polyols for insulation and packaging. Stepan maintains a competitive edge through innovation, sustainability initiatives, and strategic partnerships, positioning itself as a reliable supplier in a fragmented but growing specialty chemicals sector. The company’s global footprint, with production facilities across North America, Europe, and Asia, enhances its ability to serve multinational customers while mitigating regional demand fluctuations. Its focus on high-margin specialty products and R&D investments underscores its commitment to long-term market leadership.

Revenue Profitability And Efficiency

Stepan reported revenue of $2.18 billion for FY 2024, with net income of $50.4 million, reflecting a net margin of approximately 2.3%. Operating cash flow stood at $162.1 million, supporting capital expenditures of $122.8 million. The diluted EPS of $2.20 indicates modest profitability, though margins may face pressure from raw material volatility and competitive pricing in the chemicals sector.

Earnings Power And Capital Efficiency

The company’s operating cash flow of $162.1 million demonstrates its ability to generate earnings from core operations, though net income remains constrained by input costs and operational expenses. Capital expenditures, at $122.8 million, suggest ongoing investments in capacity and efficiency, but returns on invested capital may require closer scrutiny given the modest net income figure.

Balance Sheet And Financial Health

Stepan’s balance sheet shows $99.7 million in cash and equivalents against total debt of $682.8 million, indicating a leveraged but manageable position. The debt level warrants monitoring, particularly in light of interest rate environments, but the company’s stable cash flow generation provides a cushion for servicing obligations.

Growth Trends And Dividend Policy

Revenue growth trends are not explicitly provided, but the dividend payout of $1.52 per share suggests a commitment to shareholder returns, albeit with a yield that may appeal to income-focused investors. Future growth will likely hinge on expansion in high-margin specialty chemicals and geographic diversification.

Valuation And Market Expectations

With a diluted EPS of $2.20, Stepan’s valuation metrics will depend on sector comparables and investor sentiment toward chemical producers. Market expectations may be tempered by margin pressures, but the company’s niche focus and global reach could justify a premium in certain scenarios.

Strategic Advantages And Outlook

Stepan’s strategic advantages include its diversified product portfolio, global manufacturing base, and emphasis on sustainable chemistry. The outlook remains cautiously optimistic, with opportunities in emerging markets and green chemistry innovations offsetting cyclical industry risks. Execution on cost management and R&D will be critical to sustaining competitiveness.

Sources

Company filings, CIK 0000094049

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount